| Literature DB >> 30369859 |
Jaeouk Ahn1, Nam-Soo Kim2, Byung-Kook Lee3, Jungsun Park4, Yangho Kim5.
Abstract
BACKGROUND: We evaluated the association of blood pressure (BP) with blood levels of cadmium, lead, and cadmium and lead together (cadmium + lead) in a representative sample of adolescents from Korea.Entities:
Keywords: Blood Pressure; Cadmium; Combined Exposure; Hypertension; Lead
Mesh:
Substances:
Year: 2018 PMID: 30369859 PMCID: PMC6200904 DOI: 10.3346/jkms.2018.33.e278
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Means and 95% CI of PbB and CdB of adolescent by classification variables according to KNHANES 2010–2016
| Classification | No. | Mean (95% CI)a | ||
|---|---|---|---|---|
| PbB, µg/dL | CdB, µg/L | |||
| All | 1,776 | 1.192 (1.165–1.219) | 0.317 (0.306–0.328) | |
| Sex | ||||
| Male | 917 | 1.308 (1.268–1.348) | 0.322 (0.307–0.337) | |
| Female | 859 | 1.073 (1.037–1.111)b | 0.311 (0.296–0.328) | |
| Year | ||||
| 2010 | 365 | 1.418 (1.348–1.493) | 0.383 (0.350–0.420) | |
| 2011 | 381 | 1.285 (1.224–1.349)b | 0.333 (0.309–0.359)c | |
| 2012 | 364 | 1.153 (1.093–1.217)b | 0.302 (0.280–0.325)b | |
| 2013 | 360 | 1.192 (1.129–1.259)b | 0.238 (0.217–0.261)b | |
| 2016 | 306 | 1.001 (0.912–1.098)b | 0.337 (0.304–0.374) | |
| Age group | ||||
| 10–12 | 562 | 1.349 (1.287–1.413) | 0.270 (0.252–0.290) | |
| 13–15 | 639 | 1.178 (1.139–1.218)b | 0.330 (0.314–0.348)b | |
| 16–18 | 575 | 1.099 (1.052–1.148)b | 0.342 (0.321–0.365)b | |
| Residence area | ||||
| Urban | 1,495 | 1.182 (1.154–1.209) | 0.319 (0.307–0.331) | |
| Rural | 281 | 1.248 (1.182–1.319) | 0.307 (0.282–0.333) | |
| Exercise | ||||
| Yes | 218 | 1.270 (1.154–1.399) | 0.288 (0.258–0.322) | |
| No | 1,558 | 1.175 (1.143–1.208) | 0.324 (0.312–0.337) | |
| Walk | ||||
| Yes | 218 | 1.186 (1.092–1.288) | 0.325 (0.296–0.357) | |
| No | 1,558 | 1.193 (1.161–1.226) | 0.315 (0.303–0.328) | |
| Smoking status | ||||
| No | 1,623 | 1.181 (1.153–1.210) | 0.304 (0.294–0.315) | |
| Yes | 153 | 1.295 (1.208–1.389)c | 0.464 (0.405–0.531)b | |
| Drinking status | ||||
| No | 1,441 | 1.181 (1.151–1.211) | 0.311 (0.300–0.322) | |
| Yes | 335 | 1.233 (1.167–1.302) | 0.340 (0.311–0.371) | |
| Prehypertension | ||||
| No | 1,740 | 1.192 (1.166–1.218) | 0.317 (0.307–0.328) | |
| Yes | 36 | 1.183 (1.044–1.341) | 0.312 (0.251–0.388) | |
CI = confidence interval, PbB = blood lead, CdB = blood cadmium, KNHANES = Korean National Health and Nutrition Examination Survey.
aAdjusted for all classification variables except its own variable; bP < 0.01; cP < 0.05.
Means and 95% CIs of DBP and SBP of adolescent by classification variables according to KNHANES 2010–2016
| Classification | Mean (95% CI)a | ||
|---|---|---|---|
| DBP, mmHg | SBP, mmHg | ||
| Sex | |||
| Male (n = 917) | 66.0 (65.3–66.7) | 109.7 (108.9–110.4) | |
| Female (n = 859) | 66.9 (66.1–67.7) | 105.8 (105.0–106.7)b | |
| Year | |||
| 2010 | 66.5 (65.1–67.9) | 107.0 (105.6–108.4) | |
| 2011 | 65.2 (64.0–66.3) | 106.9 (105.6–108.1) | |
| 2012 | 66.3 (64.7–67.9) | 108.3 (106.8–109.8) | |
| 2013 | 65.4 (64.2–66.5) | 108.0 (106.7–109.3) | |
| 2016 | 68.2 (65.9–70.6) | 108.9 (106.7–111.2) | |
| Age group | |||
| 10–12 | 64.1 (63.0–65.2) | 106.6 (105.4–107.8) | |
| 13–15 | 66.4 (65.6–67.3) | 107.8 (106.9–108.7) | |
| 16–18 | 68.1 (67.1–69.0) | 108.9 (107.8–109.9)c | |
| Residence area | |||
| Urban | 66.5 (65.9–67.0) | 107.7 (107.2–108.3) | |
| Rural | 66.1 (64.9–67.3) | 108.5 (107.1–109.9) | |
| Exercise | |||
| Yes | 64.7 (62.7–66.7) | 106.9 (104.8–109.0) | |
| No | 66.8 (66.1–67.5) | 108.1 (107.4–108.8) | |
| Walk | |||
| Yes | 66.1 (64.0–68.1) | 109.0 (106.9–111.1) | |
| No | 66.5 (65.8–67.1) | 107.6 (106.9–108.3) | |
| Smoking status | |||
| No | 66.6 (66.1–67.1) | 108.0 (107.4–108.5) | |
| Yes | 64.6 (62.6–66.5) | 106.9 (105.0–108.9) | |
| Drinking status | |||
| No | 66.5 (65.9–67.0) | 107.9 (107.3–108.5) | |
| Yes | 66.2 (65.1–67.3) | 107.7 (106.4–108.9) | |
| PbB quartile | |||
| 1st | 66.9 (66.0–67.8) | 108.3 (107.3–109.3) | |
| 2nd | 67.0 (66.0–68.0) | 108.0 (106.9–109.0) | |
| 3rd | 65.5 (64.5–66.5)c | 107.4 (106.4–108.4) | |
| 4th | 66.3 (65.4–67.3) | 107.8 (106.7–108.9) | |
| CdB quartile | |||
| 1st | 67.0 (66.0–68.0) | 107.8 (106.8–108.8) | |
| 2nd | 66.2 (65.4–67.0) | 107.5 (106.5–108.5) | |
| 3rd | 65.1 (64.2–66.1)b | 107.5 (106.5–108.5) | |
| 4th | 67.3 (66.2–68.3) | 108.7 (107.5–109.9) | |
| Combined PbB & CdB quartile | |||
| Lowest | 67.5 (65.8–69.2) | 106.6 (104.8–108.4) | |
| Highest | 68.5 (66.7–70.2) | 110.0 (107.9–112.1)c | |
CI = confidence interval, DBP = diastolic blood pressure, SBP = systolic blood pressure, PbB = blood lead, CdB = blood cadmium.
aAdjusted for all classification variables except its own variable; bP < 0.01; cP < 0.05.
Differences (95% CIs) in diastolic and SBP by PbB and CdB level (continuous and quartile values) after covariate adjustmenta
| Classification | PbB only | PbB & CdB | Classification | CdB only | PbB & CdB | |||
|---|---|---|---|---|---|---|---|---|
| Model 1: DPB | ||||||||
| Per doubling of PbB, µg/dLb | −0.680 (−1.581, 0.221) | −0.696 (−1601, 0.209) | Per doubling of CdB, µg/Lb | −0.015 (−0.607, 0.576) | 0.062 (−0.533, 0.658) | |||
| PbB quartile | CdB quartile | |||||||
| 1st | 0 (Reference) | 1st | 0 (Reference) | 0 (Reference) | ||||
| 2nd | 0.065 (−2.238, 1.385) | 0.081 (−1.235, 1.396) | 2nd | −0.924 (−0.924, 0.388) | −0.845 (−2.142, 0.451) | |||
| 3rd | −1.411 (−3.330, −0.017) | −1.406 (−2.784, −0.020) | 3rd | −1.948 (−1.948, −0.566) | −1.880 (−3.246, −0.513) | |||
| 4th | −0.511 (−1.363, 0.844) | −0.582 (−1.915, 0.751) | 4th | 0.101 (0.101, 1.565) | 0.232 (−1.221, 1.686) | |||
| Model 2: SBP | ||||||||
| Per doubling of PbB, µg/dLb | −0.099 (−1.098, 0.898) | −0.222 (−0.228, 0.785) | Per doubling of CdB, µg/Lb | 0.445 (−0.178, 1.068) | 0.471 (−0.161, 1.101) | |||
| PbB quartile | CdB quartile | |||||||
| 1st | 0 (Reference) | 1st | 0 (Reference) | 0 (Reference) | ||||
| 2nd | −0.255 (−1.755, 1.223) | −0.301 (−1.787, 1.184) | 2nd | −0.346 (−1.755, 1.062) | −0.305 (−1.719, 1.107) | |||
| 3rd | −0.788 (−1.773, 0.651) | −0.859 (−2.303, 0.583) | 3rd | −0.327 (−1.773, 1.119) | −0.281 (−1.744, 1.181) | |||
| 4th | −0.304 (−0.682, 1.218) | −0.470 (−1.983, 1.041) | 4th | 0.883 (−0.682, 2.449) | 0.964 (−0.609, 2.537) | |||
PbB quartile are presented as < 1.07, 1.07–1.341, 1.342–1.655, > 1.655 µg/dL for male; < 0.839, 0.839–1.076, 1.077–1.371, > 1.371 µg/dL for female. CdB quartile are presented as < 0.223, 0.223–0.319, 0.320–0.451, > 0.451 µg/L for male; < 0.225, 0.225–0.310, 0.311–0.440, > 0.441 µg/L for female.
CI = confidence interval, SBP = systolic blood pressure, PbB = blood lead, CdB = blood cadmium, DPB = diastolic blood pressure, BMI = body mass index.
aAdjusted for sex, year, age, residence area, smoking and drinking status, physical activities, serum creatinine, BMI, and hemoglobin; bMean differences in systolic and diastolic pressure with doubling of the PbB levels.
OR (95% CI) for having prehypertension by PbB and CdB level (continuous and quartile values) after covariate adjustmenta
| Classification | PbB only | PbB & CdB | Classification | CdB only | PbB & CdB | ||
|---|---|---|---|---|---|---|---|
| Per doubling of PbB, µg/dLb | 0.906 (0.629–1.305) | 0.883 (0.613–1.271) | Per doubling of CdB, µg/Lb | 1.091 (0.896–1.327) | 1.105 (0.909–1.344) | ||
| PbB quartile | CdB quartile | ||||||
| 1st | Reference | Reference | 1st | Reference | Reference | ||
| 2nd | 0.943 (0.589–1.509) | 0.935 (0.583–1.500) | 2nd | 1.034 (0.633–1.69) | 1.047 (0.644–1.703) | ||
| 3rd | 0.797 (0.495–1.282) | 0.777 (0.481–1.253) | 3rd | 0.957 (0.581–1.577) | 0.968 (0.587–1.598) | ||
| 4th | 1.002 (0.598–1.678) | 0.950 (0.567–1.592) | 4th | 1.342 (0.850–2.117) | 1.360 (0.866–2.133) | ||
PbB quartile are presented as < 1.07, 1.07–1.341, 1.342–1.655, > 1.655 µg/dL for male; < 0.839, 0.839–1.076, 1.077–1.371, > 1.371 µg/dL for female. CdB quartile are presented as < 0.223, 0.223–0.319, 0.320–0.451, > 0.451 µg/L for male; < 0.225, 0.225–0.310, 0.311–0.440, > 0.441 µg/L for female.
OR = odds ratio, CI = confidence interval, PbB = blood lead, CdB = blood cadmium, BMI = body mass index.
aAdjusted for sex, year, age, residence area, smoking and drinking status, physical activities, serum creatinine, BMI, and hemoglobin; bOR (95% CI) for having hypertension with doubling of the CdB levels.
OR (95% CI) for having prehypertension by low and high subgroup of combined PbB and CdB after covariate adjustmenta
| Classification | Prehypertension | |
|---|---|---|
| Combined PbB & CdB quartile | ||
| Both 1st | 0 (Reference) | |
| Both 4th | 3.232 (1.078–9.682) | |
OR = odds ratio, CI = confidence interval, PbB = blood lead, CdB = blood cadmium, BMI = body mass index.
aAdjusted for sex, year, age, residence area, smoking and drinking status, physical activities, serum creatinine, BMI, and hemoglobin.